{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:33:55Z","timestamp":1792020835953,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.amjoto.2021.103086","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:04:02Z","timestamp":1621555442000},"page":"103086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis"],"prefix":"10.1016","volume":"42","author":[{"given":"Sang-Yeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bola","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marge","family":"Carandang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Won","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ha","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjoto.2021.103086_bb0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0194599816628524","article-title":"2015 equilibrium committee amendment to the 1995 AAO-HNS guidelines for the definition of Meniere\u2019s disease","volume":"154","author":"Goebel","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2021.103086_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/nyas.12699","article-title":"Meniere\u2019s disease: histopathology, cytochemistry, and imaging","volume":"1343","author":"Ishiyama","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.amjoto.2021.103086_bb0015","doi-asserted-by":"crossref","unstructured":"Rauch SD. Clinical Hints and Precipitating Factors in Patients Suffering from Meniere's Disease. Otolaryngologic Clinics of North America. [Review]. 2010;43(5):1011\u20137.","DOI":"10.1016\/j.otc.2010.05.003"},{"key":"10.1016\/j.amjoto.2021.103086_bb0020","unstructured":"Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. The American Journal of Otology1999;20(2):209\u201319."},{"issue":"4","key":"10.1016\/j.amjoto.2021.103086_bb0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","article-title":"Intratympanic gentamicin therapy for Meniere\u2019s disease: a meta-analysis","volume":"25","author":"Chia","year":"2004","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.amjoto.2021.103086_bb0030","doi-asserted-by":"crossref","unstructured":"Harner SG, Driscoll CL, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otology & Neurotology: Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2001 Mar;22(2):210\u20134.","DOI":"10.1097\/00129492-200103000-00016"},{"issue":"2","key":"10.1016\/j.amjoto.2021.103086_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5152\/iao.2018.140818","article-title":"European position statement on diagnosis, and treatment of Meniere\u2019s disease","volume":"14","author":"Magnan","year":"2018","journal-title":"J Int Adv Otol"},{"key":"10.1016\/j.amjoto.2021.103086_bb0040","doi-asserted-by":"crossref","unstructured":"Pullens B, van Benthem PP. Intratympanic gentamicin for Meniere's disease or syndrome. The Cochrane Database of Systematic Reviews2011 Mar 16(3):CD008234.","DOI":"10.1002\/14651858.CD008234.pub2"},{"issue":"10061","key":"10.1016\/j.amjoto.2021.103086_bb0045","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/S0140-6736(16)31461-1","article-title":"Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re\u2019s disease: a randomised, double-blind, comparative effectiveness trial","volume":"388","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjoto.2021.103086_bb0050","doi-asserted-by":"crossref","unstructured":"Atrache Al Attrache N, Krstulovic C, Perez Guillen V, et al. Response over time of vertigo spells to intratympanic dexamethasone treatment in Meniere's disease patients. The Journal of International Advanced Otology2016 Apr;12(1):92\u20137.","DOI":"10.5152\/iao.2016.2177"},{"issue":"1","key":"10.1016\/j.amjoto.2021.103086_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02907620","article-title":"Intratympanic dexamethasone application in Meniere\u2019s disease\u2014is it superior to conventional therapy?","volume":"57","author":"Paragache","year":"2005","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2021.103086_bb0060","unstructured":"Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. The American Journal of Otology1998 Mar;19(2):196\u2013201."},{"key":"10.1016\/j.amjoto.2021.103086_bb0065","doi-asserted-by":"crossref","unstructured":"Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2016 Sep;273(9):2271\u20138.","DOI":"10.1007\/s00405-015-3689-3"},{"issue":"4","key":"10.1016\/j.amjoto.2021.103086_bb0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/coa.13350","article-title":"Different medications for the treatment of Meniere\u2019s disease by intratympanic injection: a systematic review and network meta-analysis","volume":"44","author":"Cao","year":"2019","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.amjoto.2021.103086_bb0075","first-page":"1","article-title":"What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere\u2019s disease compared with steroids? A meta-analysis","author":"Jiang","year":"2020","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.amjoto.2021.103086_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjoto.2021.103086_bb0085","doi-asserted-by":"crossref","unstructured":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg1995 Sep;113(3):181\u20135.","DOI":"10.1016\/S0194-5998(95)70102-8"},{"key":"10.1016\/j.amjoto.2021.103086_bb0090","doi-asserted-by":"crossref","unstructured":"Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ2003 Sep 6;327(7414):557\u201360.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"10.1016\/j.amjoto.2021.103086_bb0095","unstructured":"Akkuzu B, Ozgirgin N, Ozl\u00fco\u01e7lu LN. Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing. Kulak Burun Bogaz Ihtisas Dergisi: KBB = Journal of Ear, Nose, and Throat. [Article]. 2006;16(5):193\u20139."},{"key":"10.1016\/j.amjoto.2021.103086_bb0100","unstructured":"Wang QL, Guo XD, Mei XS, et al. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery2017 Jan 20;31(2):96\u20139."},{"key":"10.1016\/j.amjoto.2021.103086_bb0105","doi-asserted-by":"crossref","unstructured":"Shcherbakov DA, Raemgulov RA, Bukharova KP, et al. [The effectiveness of the intra-tympanic administration of methylprednisolone and gentamycin for the treatment of Meniere's disease]. Vestnik Otorinolaringologii2018;83(5):17\u201320.","DOI":"10.17116\/otorino20188305117"},{"key":"10.1016\/j.amjoto.2021.103086_bb0110","doi-asserted-by":"crossref","unstructured":"Harcourt JP, Lambert A, Wong PY, et al. Long-term follow-up of intratympanic methylprednisolone versus gentamicin in patients with unilateral Meniere's disease. Otology & Neurotology: Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2019 Apr;40(4):491\u20136.","DOI":"10.1097\/MAO.0000000000002108"},{"issue":"5","key":"10.1016\/j.amjoto.2021.103086_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1067\/mhn.2001.119485","article-title":"Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere\u2019s disease","volume":"125","author":"Sennaroglu","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2021.103086_bb0120","doi-asserted-by":"crossref","unstructured":"Ul Shamas I. Short term results of intra tympanic gentamicin and dexamethasone on hearing and tinnitus in meniere's disease: a case control study. International Tinnitus Journal. [Conference Paper]. 2017;21(1):21\u20133.","DOI":"10.5935\/0946-5448.20170005"},{"key":"10.1016\/j.amjoto.2021.103086_bb0125","doi-asserted-by":"crossref","unstructured":"Casani AP, Piaggi P, Cerchiai N, et al. Intratympanic treatment of intractable unilateral m\u00e9ni\u00e8re disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngology - Head and Neck Surgery. [Article]. 2012;146(3):430\u20137.","DOI":"10.1177\/0194599811429432"},{"key":"10.1016\/j.amjoto.2021.103086_bb0130","doi-asserted-by":"crossref","unstructured":"Naples JG, Henry L, Brant JA, et al. Intratympanic therapies in M\u00e9ni\u00e8re disease: evaluation of outcomes and early vertigo control. The Laryngoscope. [Review]. 2019;129(1):216\u201321.","DOI":"10.1002\/lary.27392"},{"key":"10.1016\/j.amjoto.2021.103086_bb0135","doi-asserted-by":"crossref","unstructured":"Gabra N, Saliba I. The effect of intratympanic methylprednisolone and gentamicin injection on m\u00e9ni\u00e8re's disease. Otolaryngology - Head and Neck Surgery (United States). [Article]. 2013;148(4):642\u20137.","DOI":"10.1177\/0194599812472882"},{"key":"10.1016\/j.amjoto.2021.103086_bb0140","doi-asserted-by":"crossref","unstructured":"Sarafraz M, Saki N, Nikakhlagh S, et al. Comparison the efficacy of intratympanic injections of methylprednisolone and gentamicin to control vertigo in unilateral meniere's disease. Biomedical and Pharmacology Journal. [Article]. 2015;8SE:705\u20139.","DOI":"10.13005\/bpj\/772"},{"key":"10.1016\/j.amjoto.2021.103086_bb0145","doi-asserted-by":"crossref","unstructured":"MacArthur C, Hausman F, Kempton B, et al. Intratympanic Steroid Treatments May Improve Hearing via Ion Homeostasis Alterations and Not Immune Suppression. Otology & Neurotology: Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2015 Jul;36(6):1089\u201395.","DOI":"10.1097\/MAO.0000000000000725"},{"key":"10.1016\/j.amjoto.2021.103086_bb0150","doi-asserted-by":"crossref","unstructured":"Ishiyama G, L\u00f3pez IA, Ishiyama A. Aquaporins and Meniere's disease. Current Opinion in Otolaryngology & Head and Neck Surgery2006;14(5):332\u20136.","DOI":"10.1097\/01.moo.0000244191.51560.22"},{"key":"10.1016\/j.amjoto.2021.103086_bb0155","doi-asserted-by":"crossref","unstructured":"Liu B, Leng Y, Zhou R, et al. Intratympanic steroids injection is effective for the treatment of drop attacks with Meniere's disease and delayed endolymphatic hydrops: a retrospective study. Medicine2016;95(52).","DOI":"10.1097\/MD.0000000000005767"},{"key":"10.1016\/j.amjoto.2021.103086_bb0160","doi-asserted-by":"crossref","unstructured":"Greco A, Gallo A, Fusconi M, et al. Meniere's disease might be an autoimmune condition? Autoimmunity Reviews2012;11(10):731\u20138.","DOI":"10.1016\/j.autrev.2012.01.004"},{"key":"10.1016\/j.amjoto.2021.103086_bb0165","doi-asserted-by":"crossref","unstructured":"Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: An animal study followed by clinical application. The Laryngoscope. [Article]. 1999;109(7 II):1\u201317.","DOI":"10.1097\/00005537-199907001-00001"},{"key":"10.1016\/j.amjoto.2021.103086_bb0170","doi-asserted-by":"crossref","unstructured":"Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otology & Neurotology: Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2007 Dec;28(8):1124\u201330.","DOI":"10.1097\/MAO.0b013e31815aee21"},{"issue":"1\u20132","key":"10.1016\/j.amjoto.2021.103086_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.heares.2006.09.011","article-title":"Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H\/HeJ mice","volume":"226","author":"Trune","year":"2007","journal-title":"Hear Res"},{"key":"10.1016\/j.amjoto.2021.103086_bb0180","unstructured":"Masoumi E, Dabiri S, Khorsandi Ashtiani MT, et al. Methylprednisolone versus dexamethasone for control of vertigo in patients with definite Meniere's disease. Iranian Journal of Otorhinolaryngology2017 Nov;29(95):341\u20136."},{"issue":"11","key":"10.1016\/j.amjoto.2021.103086_bb0185","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archotol.134.11.1149","article-title":"Time course of episodes of definitive vertigo in Meniere\u2019s disease","volume":"134","author":"Perez-Garrigues","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.amjoto.2021.103086_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.otohns.2005.05.010","article-title":"Couthino De Toledo H, Hinojosa-Gonzalez R, et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere\u2019s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial","volume":"133","author":"Garduno-Anaya","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2021.103086_bb0195","doi-asserted-by":"crossref","unstructured":"Zhang Y, Fu J, Lin H, et al. The clinical outcomes after intratympanic gentamicin injection to treat Meniere's disease: a meta-analysis. Otology & Neurotology: Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2019 Apr;40(4):419\u201329.","DOI":"10.1097\/MAO.0000000000002159"},{"issue":"11","key":"10.1016\/j.amjoto.2021.103086_bb0200","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.1002\/lary.24106","article-title":"Gentamicin-induced bilateral vestibulopathy in rabbits: vestibular dysfunction and histopathology","volume":"123","author":"Kim","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.amjoto.2021.103086_bb0205","doi-asserted-by":"crossref","unstructured":"Simo H, Yang S, Qu W, et al. Meniere's disease: importance of socioeconomic and environmental factors. American Journal of Otolaryngology2015 May-Jun;36(3):393\u20138.","DOI":"10.1016\/j.amjoto.2015.01.009"},{"key":"10.1016\/j.amjoto.2021.103086_bb0210","doi-asserted-by":"crossref","unstructured":"Mohamed S, Khan I, Iliodromiti S, et al. Meniere's disease and underlying medical and mental conditions: towards factors contributing to the disease. ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties2016;78(3):144\u201350.","DOI":"10.1159\/000444931"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:06:54Z","timestamp":1759295214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070921001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0196070921001873"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103086","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103086"}}